港A兩地豬肉股普跌 萬洲國際(0288.HK)跌3.5%
格隆匯11月20日丨今日港A兩地豬肉股普跌,A股市場上,天康生物、龍大肉食和牧原股份跌超3%,天邦股份跌2.9%,正邦科技、新五豐、新希望、傲農生物、大北農和唐人神等均出現一定程度的下跌;港股市場上,萬洲國際跌3.5%,中糧肉食跌2.5%。據農業農村部信息中心監測,上週(11月11日至15日),內地16省瘦肉型白條豬肉出廠價格指數平均值為每公斤46.11元人民幣,環比跌9.6%,同比則大幅上漲156.5%.肉價環比下跌主要因為養殖户和規模養殖場出欄生豬的積極性提升,加之凍肉集中投放市場,造成豬肉供應過剩,但終端需求疲軟,帶動多地生豬和豬肉價格下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.